The Speech Accessibility Project is a research initiative to make voice recognition technology more useful for people with a range of diverse speech patterns and disabilities. The project is housed ...

Mabylon has received grants from Target ALS and the ALS Association to develop human-derived antibodies to help restore ...

The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.

Direct-to-participant study to reach 150 people living with ALS, with 2 participants already enrolled.

A tailored cocktail of genes can reprogram a subset of progenitors to no longer produce glial cells and instead develop into neurons involved in motor control.

A New Bedford man, Joseph Smith, admitted to stealing over $450,000 in disability benefits from a veteran with ALS and ...

Spinogenix, the company behind the once-a-day pill that restored lost nerve cell connections in people with amyotrophic ...

PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cellular therapies for a range of autoimmune diseases, today announces it has launched a study with ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Mayo Clinic researchers have just been awarded a new federal grant to start an investigation of an experimental drug on ...

Jason McCarthy, an analyst from Maxim Group, maintained the Buy rating on Brainstorm Cell Therapeutics (BCLI – Research Report). The ...

A group of eight molecules in the blood can be used as a biomarker to distinguish ALS from other neurodegenerative conditions ...